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Investigations over the past 10 years have shown that the immune system is involved in the development of atherosclerosis. There is evidence for an inflammatory process in the vessel wall and also for an involvement of specific immunological mechanisms in atherogenesis.
The data can be summarised as follows: (a) immunoglobulins as well as T lymphocytes and macrophages are found in large numbers in the atherosclerotic plaque; (b) B lymphocytes and plasma cells can often be detected in the adventitia adjacent to advanced plaques; (c) antibodies to antigens present in plaques can be detected in atherosclerotic individuals; (d) immunocompetent cells are recruited to the arterial intima early in the development of atherosclerosis-like lesions in laboratory animals; and (e) T cell depletion can significantly modify the development of vascular lesions in animal models.
From all these studies it is clear that components of the immune system are involved in atherosclerosis-but they do not elicit the disease process. Immune mechanisms seem to be potent modulators of the atherosclerotic process. It is, however, important to realise the complexity of these mechanisms. The immune system is, together with the nervous system, the most complicated organ system in the human body. Its organisation in interconnecting networks with counterbalancing factors makes it unrealistic to attempt to reduce its involvement in atherosclerosis into a simplistic "good" or "bad" function.
Intraplaque cellular immune responses in atherosclerosis Immunohistochemical analysis using monoclonal antibodies for specific cell types has shown that the lipid-rich core region of advanced human atherosclerotic plaques is dominated by macrophages. ' 
